Higher drug costs may be attributable to either high initial doses or a dose increase.
Xing-yue Huang, PhD
Advertisement
Articles by Xing-yue Huang, PhD
Advertisement
Latest Updated Articles
- Claims Data Analysis of Dosing and Cost of TNF Antagonist
Published: December 22nd 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
3
Breaking News: CVS Buys Rite Aid, Bartell Drugs
4
Current and Emerging BCMAxCD3 Bispecifics
5
